arrow
J

Judith L. Gulikers

maastricht university medical center+
H指数:6
被引数:89

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real world effectiveness of durvalumab in stage III unresectable non-small cell lung cancer: what is the role of PD-L1 expression?

III期不可切除非小细胞肺癌 durvalumab 的真实世界有效性:PD-L1 表达的作用是什么?

2025-07-170
OAAI
Osimertinib Plasma Trough Concentration in Relation to Brain Metastases Development in Patients With Advanced EGFR-Mutated NSCLC

奥希替尼血浆谷浓度与晚期EGFR突变NSCLC患者脑转移发生的关系

2024-04-011
OA
Exploring the impact of patient-specific clinical features on osimertinib effectiveness in a real-world cohort of patients with EGFR mutated non-small cell lung cancer
2023-10-156
OA
Peripheral osimertinib (osi) plasma trough concentration (Cmin,SS) as surrogate parameter for development and progression of brain metastasis (BM) in patients (pts) with EGFR plus advanced non-small cell lung cancer (aNSCLC)
2023-10-010
OAAI